Secondary |
Malignant Melanoma |
24.0% |
Product Used For Unknown Indication |
21.6% |
Insomnia |
7.8% |
Immunisation |
6.6% |
Depression |
4.8% |
Phobia |
4.8% |
Hypothyroidism |
3.0% |
Prophylaxis |
3.0% |
Pyrexia |
3.0% |
Vitamin Supplementation |
3.0% |
Anxiety |
2.4% |
Candidiasis |
2.4% |
Glaucoma |
2.4% |
Rhinitis |
2.4% |
Urinary Retention |
2.4% |
Hypersensitivity |
1.8% |
Bacterial Infection |
1.2% |
Colitis |
1.2% |
Drug Exposure Via Breast Milk |
1.2% |
Exposure During Breast Feeding |
1.2% |
|
Neoplasm Malignant |
24.2% |
Weight Increased |
12.1% |
Coma |
9.1% |
Vomiting |
6.1% |
Death |
3.0% |
Disseminated Intravascular Coagulation |
3.0% |
Fatigue |
3.0% |
Heart Rate Abnormal |
3.0% |
Liver Disorder |
3.0% |
Liver Injury |
3.0% |
Maternal Drugs Affecting Foetus |
3.0% |
Nasopharyngitis |
3.0% |
Pain |
3.0% |
Platelet Count Decreased |
3.0% |
Pregnancy |
3.0% |
Pyrexia |
3.0% |
Rash Erythematous |
3.0% |
Renal Injury |
3.0% |
Respiratory Disorder |
3.0% |
Roseola |
3.0% |
|
Concomitant |
Metastatic Renal Cell Carcinoma |
19.2% |
Prophylaxis |
10.5% |
Rheumatoid Arthritis |
8.8% |
Hypersensitivity |
6.7% |
Insomnia |
6.7% |
Product Used For Unknown Indication |
4.6% |
Hypothyroidism |
4.2% |
Hypertension |
3.8% |
Psoriasis |
3.8% |
Depression |
3.3% |
Drug Use For Unknown Indication |
3.3% |
Phobia |
3.3% |
Prostate Cancer Metastatic |
3.3% |
Bronchiectasis |
2.9% |
Idiopathic Thrombocytopenic Purpura |
2.9% |
Anaemia |
2.5% |
Asthma |
2.5% |
Bronchitis |
2.5% |
Chronic Obstructive Pulmonary Disease |
2.5% |
Osteoporosis |
2.5% |
|
Pruritus |
9.3% |
Weight Increased |
9.3% |
Psoriasis |
7.4% |
Tremor |
7.4% |
Diarrhoea |
5.6% |
Dyspnoea |
5.6% |
Herpes Zoster |
5.6% |
Therapeutic Response Decreased |
5.6% |
Asthma |
3.7% |
Herpes Zoster Disseminated |
3.7% |
Morphoea |
3.7% |
Mucous Stools |
3.7% |
Pain |
3.7% |
Peripheral Sensory Neuropathy |
3.7% |
Pneumonia |
3.7% |
Scleral Disorder |
3.7% |
Somnolence |
3.7% |
Swelling |
3.7% |
Teeth Brittle |
3.7% |
Viral Infection |
3.7% |
|
Interacting |
Type 2 Diabetes Mellitus |
80.0% |
Hypertension |
20.0% |
|
|